BPU-11

CAS No. 909664-41-1

BPU-11( BPU 11 | BPU11 | Biphenyl Urea 11 )

Catalog No. M24949 CAS No. 909664-41-1

BPU-11 is an HCN4 CLP ligand that acts by modulating channel function and completely abolishing the cAMP-induced shift in V1/2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 38 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BPU-11
  • Note
    Research use only, not for human use.
  • Brief Description
    BPU-11 is an HCN4 CLP ligand that acts by modulating channel function and completely abolishing the cAMP-induced shift in V1/2.
  • Description
    BPU-11 is an HCN4 CLP ligand that acts by modulating channel function and completely abolishing the cAMP-induced shift in V1/2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BPU 11 | BPU11 | Biphenyl Urea 11
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    909664-41-1
  • Formula Weight
    501.63
  • Molecular Formula
    C32H31N5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1CN(CCC1N(CC2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CC=CC=C4)CC5=CC(=CC=C5)C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Iobenguane sulfate

    Iobenguane sulfate is a high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation). Radioiodinated Iobenguane sulfate is clinically used as a tumor-targeted radiopharmaceutical in the diagnosis and treatment of adrenergic tumors.

  • Estredox

    Estredox (E2 CDS) is a redox-based estradiol (E2) chemical delivery system.E2-CDS provides sustained and brain-selective delivery of estradiol.

  • Ziftomenib

    Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity, suitable for leukemia research.